CVR: 12927983
ABIGO PHARMA A/S was a Danish company of the type Aktieselskab based in Allerød, founded in 1989 and dissolved in 2024. The company was registered under the industry Specialiseret engroshandel med fødevarer i.a.n.. The company has 8 employees. In 2023, the company reported revenue of DKK 9,189,036 and a net result of DKK 201,721 compared with DKK 165,903 the year before. Equity amounted to DKK 4,838,794.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2023 | 9.2 mio. | 202 t. | 6 mio. | 4.8 mio. | 1 | |
| 2022 | 12.9 mio. | 166 t. | 6.4 mio. | 4.6 mio. | 4 | |
| 2021 | - | 4.6 mio. | 8 mio. | 4.5 mio. | 7 | |
| 2020 | - | 155 t. | 6.8 mio. | -159 t. | 8 | |
| 2019 | - | -146 t. | 6.5 mio. | -314 t. | 8 | |
| 2018 | - | -240 t. | 5.7 mio. | -168 t. | 8 | |
| 2017 | - | 138 t. | 6.1 mio. | -203 t. | - | |
| 2016 | - | 642 t. | 5.7 mio. | -341 t. | - | |
| 2015 | - | 778 | 7.8 mio. | -983 t. | - | |
| 2014 | - | 91 t. | 5.9 mio. | -984 t. | - | |
| 2013 | - | 85 t. | 5.5 mio. | -1.1 mio. | - |
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationScreen owners and management against the Danish FSA's official PEP lists
ABIGO PHARMA A/S has published its annual report for 2023. Revenue came to DKK 9,189,036, and the net result was DKK 201,721.
As of June 27, 2024, EY Godkendt Revisionspartnerselskab has stepped down as auditor of ABIGO PHARMA A/S.
As of June 27, 2024, Christina Maria Rydebrink has left the board of directors of ABIGO PHARMA A/S.
As of June 27, 2024, Erik Johan Brobjer has left the board of directors of ABIGO PHARMA A/S.
As of June 27, 2024, Erik Johan Brobjer has stepped down as adm. dir. of ABIGO PHARMA A/S.
As of June 27, 2024, Ulrika Wictoria Wilson has stepped down as chairman of ABIGO PHARMA A/S.
ABIGO PHARMA A/S was dissolved on June 27, 2024.
As of October 3, 2023, Erik Johan Brobjer has joined the board of directors of ABIGO PHARMA A/S.
As of October 3, 2023, Fredrik Ralph Stenbäcker has left the board of directors of ABIGO PHARMA A/S.
As of October 3, 2023, Erik Johan Brobjer is registered as adm. dir. of ABIGO PHARMA A/S.
As of October 3, 2023, Ulrika Wictoria Wilson is registered as chairman of ABIGO PHARMA A/S.
As of October 3, 2023, Johan Lindberg has stepped down as chairman of ABIGO PHARMA A/S.
As of October 3, 2023, Fredrik Ralph Stenbäcker has stepped down as adm. dir. of ABIGO PHARMA A/S.
ABIGO PHARMA A/S has published its annual report for 2022. Revenue came to DKK 12,886,055, and the net result was DKK 165,903.
ABIGO PHARMA A/S has published its annual report for 2021. Gross profit came to DKK 12,897,966, and the net result was DKK 4,629,963.
As of April 11, 2022, EY Godkendt Revisionspartnerselskab has been appointed auditor of ABIGO PHARMA A/S.
As of April 11, 2022, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of ABIGO PHARMA A/S.
As of November 30, 2021, Christina Maria Rydebrink has joined the board of directors of ABIGO PHARMA A/S.
As of November 30, 2021, Frank Åke Joakim Jehlbo has left the board of directors of ABIGO PHARMA A/S.
As of November 30, 2021, Johan Lindberg is registered as chairman of ABIGO PHARMA A/S.
As of November 30, 2021, Fredrik Ralph Stenbäcker is registered as adm. dir. of ABIGO PHARMA A/S.
As of November 30, 2021, Wentzel Bohn-Willeberg has stepped down as chairman of ABIGO PHARMA A/S.
As of November 30, 2021, Frank Åke Joakim Jehlbo has stepped down as adm. dir. of ABIGO PHARMA A/S.
As of November 29, 2021, Johan Lindberg has left the board of directors of ABIGO PHARMA A/S.
ABIGO PHARMA A/S has published its annual report for 2020. Gross profit came to DKK 6,205,070, and the net result was DKK 155,360.
As of September 1, 2020, Fredrik Ralph Stenbäcker has joined the board of directors of ABIGO PHARMA A/S.
As of September 1, 2020, Artur Bernardino Aira has left the board of directors of ABIGO PHARMA A/S.
As of August 1, 2020, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of ABIGO PHARMA A/S.
As of August 1, 2020, ADDERE REVISION STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of ABIGO PHARMA A/S.
As of April 30, 2020, Artur Bernardino Aira has joined the board of directors of ABIGO PHARMA A/S.
As of April 30, 2020, Johan Lindberg has joined the board of directors of ABIGO PHARMA A/S.
As of April 30, 2020, Jan Smith has left the board of directors of ABIGO PHARMA A/S.
As of April 30, 2020, Wentzel Bohn-Willeberg is registered as chairman of ABIGO PHARMA A/S.
As of April 29, 2020, Wentzel Bohn-Willeberg has left the board of directors of ABIGO PHARMA A/S.
As of April 29, 2020, Johan Lindberg has stepped down as suppleant of ABIGO PHARMA A/S.
ABIGO PHARMA A/S has published its annual report for 2019. Gross profit came to DKK 5,794,340, and the net result was DKK -146,039.
As of December 31, 2019, Leif Smith has left the board of directors of ABIGO PHARMA A/S.
ABIGO PHARMA A/S has published its annual report for 2018. Gross profit came to DKK 5,740,396, and the net result was DKK -240,139.
As of December 31, 2018, Bjarne Dennis Reffeldt Otte has left the board of directors of ABIGO PHARMA A/S.
ABIGO PHARMA A/S has published its interim report for the period May 1, 2017 – December 31, 2017.
As of April 3, 2018, Frank Åke Joakim Jehlbo has joined the board of directors of ABIGO PHARMA A/S.
As of April 3, 2018, Frank Åke Joakim Jehlbo is registered as adm. dir. of ABIGO PHARMA A/S.
As of April 3, 2018, Bjarne Dennis Reffeldt Otte has stepped down as adm. dir. of ABIGO PHARMA A/S.
ABIGO PHARMA A/S has published its annual report for 2017. Gross profit came to DKK 5,325,623, and the net result was DKK 138,378.
As of March 29, 2017, Johan Lindberg is registered as suppleant of ABIGO PHARMA A/S.
As of March 29, 2017, Per-Oluf Nilsson has stepped down as suppleant of ABIGO PHARMA A/S.
ABIGO PHARMA A/S has published its annual report for 2016. Gross profit came to DKK 5,766,468, and the net result was DKK 642,085.
As of February 20, 2016, Carl Magnus Anders Elliot has stepped down as suppleant of ABIGO PHARMA A/S.
ABIGO PHARMA A/S has published its annual report for 2015. Gross profit came to DKK 3,522,101, and the net result was DKK 778.
As of July 10, 2015, Bjarne Dennis Reffeldt Otte has joined the board of directors of ABIGO PHARMA A/S.
As of July 10, 2015, Claes Dahl has left the board of directors of ABIGO PHARMA A/S.
As of July 10, 2015, Bjarne Dennis Reffeldt Otte is registered as adm. dir. of ABIGO PHARMA A/S.
As of July 10, 2015, Per-Oluf Nilsson is registered as suppleant of ABIGO PHARMA A/S.
As of July 10, 2015, Claes Dahl has stepped down as adm. dir. of ABIGO PHARMA A/S.
As of July 7, 2015, Carl Magnus Anders Elliot is registered as suppleant of ABIGO PHARMA A/S.
ABIGO PHARMA A/S has published its annual report for 2014. Gross profit came to DKK 2,772,048, and the net result was DKK 91,006.
ABIGO PHARMA A/S has published its annual report for 2013. Gross profit came to DKK 2,685,684, and the net result was DKK 84,561.
As of July 1, 2012, ADDERE REVISION STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of ABIGO PHARMA A/S.
As of July 1, 2012, MJAKP2 I/S has stepped down as auditor of ABIGO PHARMA A/S.
As of December 19, 2006, Claes Dahl has joined the board of directors of ABIGO PHARMA A/S.
As of December 19, 2006, Claes Dahl is registered as adm. dir. of ABIGO PHARMA A/S.
As of December 19, 2006, Henrik Jensen has stepped down as adm. dir. of ABIGO PHARMA A/S.
As of October 25, 2005, Arne Paalberg has left the board of directors of ABIGO PHARMA A/S.
As of August 22, 2003, Henrik Jensen is registered as adm. dir. of ABIGO PHARMA A/S.
As of August 22, 2003, Finn Dyrby Hermansen has stepped down as director of ABIGO PHARMA A/S.
As of January 16, 2003, MJAKP2 I/S has been appointed auditor of ABIGO PHARMA A/S.
As of January 16, 2003, MJAKP2 I/S has stepped down as auditor of ABIGO PHARMA A/S.
As of March 6, 1996, Jørgen Sandstrøm Lindeberg has left the board of directors of ABIGO PHARMA A/S.
As of July 27, 1993, Henry Erik Mikkelsen has left the board of directors of ABIGO PHARMA A/S.
As of December 27, 1990, RISHØJ REVISION ApS has stepped down as auditor of ABIGO PHARMA A/S.
As of December 27, 1990, Henry Erik Mikkelsen has stepped down as director of ABIGO PHARMA A/S.
As of November 7, 1989, Erik Tronborg Andersen has stepped down as auditor of ABIGO PHARMA A/S.
As of November 7, 1989, Susanne Saul Stakemann has left the board of directors of ABIGO PHARMA A/S.
As of November 7, 1989, Per Emil Hasselbalch Stakemann has stepped down as director of ABIGO PHARMA A/S.
As of March 1, 1989, MJAKP2 I/S has been appointed auditor of ABIGO PHARMA A/S.
As of March 1, 1989, Erik Tronborg Andersen has been appointed auditor of ABIGO PHARMA A/S.
As of March 1, 1989, RISHØJ REVISION ApS has been appointed auditor of ABIGO PHARMA A/S.
As of March 1, 1989, Jørgen Sandstrøm Lindeberg has joined the board of directors of ABIGO PHARMA A/S.
As of March 1, 1989, Wentzel Bohn-Willeberg has joined the board of directors of ABIGO PHARMA A/S.
As of March 1, 1989, Susanne Saul Stakemann has joined the board of directors of ABIGO PHARMA A/S.
As of March 1, 1989, Henry Erik Mikkelsen has joined the board of directors of ABIGO PHARMA A/S.
As of March 1, 1989, Leif Smith has joined the board of directors of ABIGO PHARMA A/S.
As of March 1, 1989, Jan Smith has joined the board of directors of ABIGO PHARMA A/S.
As of March 1, 1989, Arne Paalberg has joined the board of directors of ABIGO PHARMA A/S.
As of March 1, 1989, Finn Dyrby Hermansen is registered as director of ABIGO PHARMA A/S.
As of March 1, 1989, Per Emil Hasselbalch Stakemann is registered as director of ABIGO PHARMA A/S.
As of March 1, 1989, Henry Erik Mikkelsen is registered as director of ABIGO PHARMA A/S.
ABIGO PHARMA A/S was founded on March 1, 1989.
Companies in the same industry and area
CVR 15353074
CVR 42366641
CVR 38012495
CVR 44262266
companydata.dk